KORU Medical Systems, Inc.
KRMD
$4.30
$0.040.94%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 20.93% | 17.53% | 23.00% | 16.80% | 21.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.93% | 17.53% | 23.00% | 16.80% | 21.54% |
| Cost of Revenue | 26.05% | 15.97% | 14.74% | 12.51% | -3.20% |
| Gross Profit | 18.18% | 18.48% | 28.44% | 19.43% | 40.94% |
| SG&A Expenses | 1.21% | 11.23% | 16.24% | 10.90% | 0.31% |
| Depreciation & Amortization | -3.85% | -6.05% | -7.36% | 5.46% | 2.35% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.20% | 7.10% | 11.13% | 12.38% | -5.30% |
| Operating Income | 73.77% | 36.52% | 27.67% | 4.90% | 63.03% |
| Income Before Tax | 80.83% | 39.76% | 22.89% | 5.26% | 68.06% |
| Income Tax Expenses | -- | -- | -99.95% | -- | -- |
| Earnings from Continuing Operations | 79.07% | 39.76% | 79.09% | -15.53% | 60.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 79.07% | 39.76% | 79.09% | -15.53% | 60.39% |
| EBIT | 73.77% | 36.52% | 27.67% | 4.90% | 63.03% |
| EBITDA | 89.41% | 40.60% | 24.15% | 6.32% | 67.65% |
| EPS Basic | 79.17% | 40.09% | 79.14% | -15.00% | 60.51% |
| Normalized Basic EPS | 80.74% | 40.00% | 24.19% | 5.70% | 68.16% |
| EPS Diluted | 79.17% | 40.09% | 79.14% | -15.00% | 60.51% |
| Normalized Diluted EPS | 80.74% | 40.00% | 24.19% | 5.70% | 68.16% |
| Average Basic Shares Outstanding | 0.83% | 0.59% | 0.36% | 0.46% | 0.45% |
| Average Diluted Shares Outstanding | 0.83% | 0.59% | 0.36% | 0.46% | 0.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |